Andreas Halvorsen - Viking Global Investors
Holding/activity history for Roivant Sciences Ltd (ROIV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 6,652,448 | 0.52 | Add 3.25% | 0.02 | $27.70 | $184,272,810 | SEC |
| 2025 Q4 | 6,443,191 | 0.37 | Reduce 72.69% | 0.68 | $21.70 | $139,817,245 | SEC |
| 2025 Q3 | 23,594,831 | 0.93 | Reduce 31.09% | 0.35 | $15.13 | $356,989,793 | SEC |
| 2025 Q2 | 34,237,779 | 1.12 | Reduce 25.59% | 0.38 | $11.27 | $385,859,769 | SEC |
| 2025 Q1 | 46,013,752 | 1.48 | Reduce 3.76% | 0.07 | $10.09 | $464,278,758 | SEC |
| 2024 Q4 | 47,809,960 | 1.83 | Reduce 11.63% | 0.27 | $11.83 | $565,591,827 | SEC |
| 2024 Q3 | 54,099,066 | 2.28 | Reduce 21.77% | 0.61 | $11.54 | $624,303,222 | SEC |
| 2024 Q2 | 69,155,846 | 2.81 | Reduce 0.31% | <0.01 | $10.57 | $730,977,292 | SEC |
| 2024 Q1 | 69,368,961 | 2.72 | $10.54 | $731,148,849 | SEC | ||
| 2023 Q4 | 69,368,961 | 2.86 | Reduce 5.54% | 0.19 | $11.23 | $779,013,432 | SEC |
| 2023 Q3 | 73,434,301 | 3.49 | Reduce 2.40% | 0.07 | $11.68 | $857,712,636 | SEC |
| 2023 Q2 | 75,238,700 | 3.12 | Reduce 14.73% | 0.45 | $10.08 | $758,406,096 | SEC |
| 2023 Q1 | 88,238,700 | 3.07 | $7.38 | $651,201,606 | SEC | ||
| 2022 Q4 | 88,238,700 | 3.54 | $7.99 | $705,027,213 | SEC | ||
| 2022 Q3 | 88,238,700 | 1.32 | $3.22 | $284,129,000 | SEC | ||
| 2022 Q2 | 88,238,700 | 1.65 | $4.07 | $359,132,000 | SEC | ||
| 2022 Q1 | 88,238,700 | 1.77 | $4.94 | $435,899,000 | SEC | ||
| 2021 Q4 | 88,238,700 | 2.58 | Buy | 2.58 | $10.08 | $889,446,000 | SEC |